Core Insights - National Health Investors (NHI) reported revenue of $82.94 million for the quarter ended September 2024, reflecting a 3.5% increase year-over-year [1] - Earnings per share (EPS) for the quarter was $1.03, up from $0.68 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $80.7 million by 2.78%, while the EPS fell short of the consensus estimate of $1.07 by 3.74% [1] Revenue Breakdown - Rental income was $63.32 million, surpassing the average estimate of $62.52 million, with a year-over-year increase of 1.7% [3] - Interest income and other revenues totaled $5.86 million, slightly above the estimated $5.81 million, marking a 6.8% increase from the previous year [3] - Resident fees and services generated $13.77 million, exceeding the estimate of $13.53 million, representing an 11.4% year-over-year growth [3] Stock Performance - Over the past month, shares of National Health Investors have declined by 6.1%, compared to a 0.5% decrease in the Zacks S&P 500 composite [4] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [4]

Core Viewpoint - National Health Investors (NHI) reported quarterly funds from operations (FFO) of $1.03 per share, missing the Zacks Consensus Estimate of $1.07 per share, representing a -3.74% surprise [1] - The company posted revenues of $82.94 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 2.78% [2] Financial Performance - NHI's FFO for the same quarter last year was $1.08 per share, indicating a year-over-year decline [1] - Over the last four quarters, NHI has surpassed consensus FFO estimates three times [2] - The company has also topped consensus revenue estimates three times over the last four quarters [2] Stock Performance - NHI shares have increased approximately 35.9% since the beginning of the year, outperforming the S&P 500's gain of 19.8% [3] - The current consensus FFO estimate for the coming quarter is $1.13 on revenues of $85.08 million, and for the current fiscal year, it is $4.48 on revenues of $329.27 million [7] Industry Outlook - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the top 27% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in estimate revisions, which can impact NHI's stock performance [5]

Financial Performance - Net income attributable to common stockholders per diluted common share for Q3 2024 was $0.65, down from $0.68 in Q3 2023[1]. - NAREIT FFO per diluted common share for Q3 2024 was $1.03, compared to $1.08 in Q3 2023[2]. - Normalized FAD for Q3 2024 was $49.4 million, an increase from $48.2 million in Q3 2023[4]. - Net income attributable to common stockholders for the third quarter of 2024 was $28.5 million, compared to $29.3 million in the same period last year[31]. - Net income for Q3 2024 was $28,242,000, a decrease of 2.7% from $29,033,000 in Q3 2023[32]. - The company recorded a net income of $94.7 million for the nine months ended September 30, 2024, compared to $103.6 million for the same period in 2023[31]. Revenue and Income Sources - Rental income recognized from tenants increased by $1.1 million, or 1.7%, in Q3 2024[7]. - Rental income rose to $63,318,000, compared to $62,255,000 in Q3 2023, reflecting a growth of 1.7%[39]. - Resident fees and services increased to $13,771,000, up 11.4% from $12,367,000 in Q3 2023[39]. Operating Metrics - Net operating income (NOI) from the Senior Housing Operating Portfolio (SHOP) segment totaled $3.0 million, a 30.4% increase year-over-year[8]. - Consolidated net operating income (NOI) increased to $69,414,000, up 3.4% from $67,153,000 in the same quarter last year[32]. - The average occupancy for the SHOP portfolio improved to 88.6%, with a year-over-year increase of 960 basis points[9]. - NHI's same-store occupancy for SLC properties was 84.0% in September 2024, slightly down from 84.3% in August 2024[24]. - The company reported a decrease in same-store occupancy for SHOP properties to 89.1% in September 2024 from 88.5% in August 2024[24]. Guidance and Projections - NHI updated its 2024 annual guidance for NAREIT FFO per diluted common share to a range of $4.39 - $4.41, down from $4.50 - $4.54[6]. - The company expects NAREIT FFO attributable to common stockholders to be in the range of $193.8 million to $194.4 million for 2024[25]. - NHI's normalized FFO per diluted common share is projected to be between $4.43 and $4.44 for 2024[25]. - SHOP NOI growth is anticipated to be between 28% and 30% year over year[25]. Investment and Debt - NHI closed on $205.6 million in new investments in 2024 with an average initial yield of 8.4%[9]. - As of September 30, 2024, NHI had $1.1 billion in net debt, including $319.0 million outstanding on its revolving credit facility[18]. - NHI has approximately $350.0 million in a pipeline of investment opportunities, excluding portfolio deals[17]. - Debt increased slightly to $1,136,302 thousand from $1,135,051 thousand, an increase of approximately 0.1%[40]. Shareholder Metrics - The weighted average diluted common shares outstanding increased to 43,987,072 in September 2024 from 43,388,841 in August 2024[28]. - The weighted average diluted shares outstanding increased to 43,987,072 from 43,388,841 in the previous year[39]. - Earnings per common share (diluted) was $0.65, down from $0.68 in Q3 2023[39]. Expenses and Financial Position - Total expenses for the quarter were $54,804,000, an increase from $52,012,000 in Q3 2023, representing a rise of 5.4%[39]. - Interest expenses decreased slightly to $14,939,000 from $15,086,000 in Q3 2023[39]. - Real estate properties, net decreased to $2,096,824 thousand from $2,107,082 thousand, a decline of approximately 0.4%[40]. - Cash and cash equivalents decreased to $15,550 thousand from $22,347 thousand, a decline of approximately 30.5%[40]. - Stockholders' equity decreased to $1,228,950 thousand from $1,253,952 thousand, a decline of approximately 2.0%[40]. Risks and Challenges - The company continues to face risks related to tenant performance and potential bankruptcy proceedings[40]. - Future performance may be impacted by changes in governmental regulations and reimbursement rates affecting tenants[40]. Upcoming Events - NHI will host a conference call on November 6, 2024, to discuss third quarter results[27].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission File Number 001-10822 National Health Investors, Inc. (Exact name of registrant as specified in its charter) Maryla ...

National Health Investors (NHI) has been on a downward spiral lately with significant selling pressure. After declining 10.2% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier. How to Determine if a Stock is Oversold We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spottin ...

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios. There is often a debate between whether rental properties or REITs are better for investors. To be sure, there are distinct advantages when it comes to rent ...

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Group 1: Company Overview - National Health Investors (NHI) currently holds a Momentum Style Score of A, indicating strong potential for momentum investing [3] - NHI has a Zacks Rank of 2 (Buy), suggesting it is positioned for outperformance in the market [4] Group 2: Price Performance - Over the past week, NHI shares increased by 5.84%, outperforming the Zacks REIT and Equity Trust - Other industry, which rose by 3.92% [6] - In a longer timeframe, NHI shares have risen by 24.15% over the past quarter and 57.29% over the last year, significantly outperforming the S&P 500's gains of 8.19% and 26.56%, respectively [7] Group 3: Trading Volume - NHI's average 20-day trading volume is 259,269 shares, which serves as a bullish indicator when combined with rising stock prices [8] Group 4: Earnings Outlook - In the past two months, two earnings estimates for NHI have been revised upwards, increasing the consensus estimate from $4.40 to $4.52 [10] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions, indicating positive earnings momentum [10]

National Health Investors, Inc. (NYSE:NHI) Q2 2024 Earnings Conference Call August 7, 2024 11:00 AM ET Company Participants Dana Hambly - Director of IR Eric Mendelsohn - President and CEO Kevin Pascoe - Chief Investment Officer John Spaid - Chief Financial Officer Conference Call Participants Robin Haneland - BMO Capital Markets Rich Anderson - Wedbush John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Capital Markets Operator Good morning, everyone, and welcome to the National Health Investors Sec ...

For the quarter ended June 2024, National Health Investors (NHI) reported revenue of $84.97 million, up 28.6% over the same period last year. EPS came in at $1.18, compared to $0.92 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $81.5 million, representing a surprise of +4.26%. The company delivered an EPS surprise of +7.27%, with the consensus EPS estimate being $1.10. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings ...

National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.18 per share, beating the Zacks Consensus Estimate of $1.10 per share. This compares to FFO of $1.06 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an FFO surprise of 7.27%. A quarter ago, it was expected that this health care real estate investment trust would post FFO of $1.05 per share when it actually produced FFO of $1.10, delivering a surprise of 4.76%. ...